Multiple Daily Insulin Injections Improve Self‐confidence

C. Houtzagers,P. A. Berntzen,H. Stap,W. Maarschalkerweerd,R. Heine,E. Veen,A. Visser

DOI: https://doi.org/10.1111/j.1464-5491.1989.tb01219.x

IF: 3.5

1989-08-01

Diabetic Medicine

Abstract:The efficacy and psychosocial effects of multiple daily insulin injections (three preprandial injections of short‐acting insulin (NovoPen) and once daily, bedtime extended‐acting insulin) were compared with those of twice daily combinations of short‐ and intermediate‐acting insulin, in a randomized crossover study (two 6‐month periods), in 16 adult diabetic patients. HbA, was not significantly different for the two treatment modalities (8.2 ± 0.4 vs 7.6 ± 0.4 %). With the pen‐injector regimen significantly less state anxiety (36.0 ± 2.5 vs 39.5 ± 2.7; p < 0.05) was found than with the conventional syringe regimen. The patients tended to experience a better self‐concept as having diabetes (32.0 ± 2.1 vs 37.7 ± 3.0; p < 0.06), as well as less external (‘chance’) orientation (18.5 ± 1.2 vs 20.7 ± 1.6; p = 0.09) with the pen‐injector regimen. A subgroup of patients with lower trait anxiety scores experienced less state anxiety during the pen‐injector regimen than during twice daily insulin injections (30.6 ± 2.6 vs 34.3 ± 2.7; p < 0.05). However, this subgroup tended to be less positive about injecting insulin during the pen‐injector regimen (34.8 ± 3.6 vs 29.6 ± 4.0; p < 0.08). The subgroup with higher trait anxiety scores experienced a better self‐concept as having diabetes (35.3 ± 2.3 vs 40.1 ± 2.6; p < 0.05) and a tendency towards less physician orientation (15.8 ± 1.8 vs 19.6 ± 2.7; p < 0.07) with the pen‐injector regimen. Thirteen patients continued with the pen‐injector regimen.